Produktname:(S)-22-(tert-Butoxycarbonyl)-45,45-dimethyl-10,19,24,43-tetraoxo-3,6,12,15,44-pentaoxa-9,18,23-triazahexatetracontanoic acid

IUPAC Name:2-(2-{2-[2-(2-{2-[(4S)-5-(tert-butoxy)-4-[20-(tert-butoxy)-20-oxoicosanamido]-5-oxopentanamido]ethoxy}ethoxy)acetamido]ethoxy}ethoxy)acetic acid

CAS:1188328-37-1
Molekulare Formel:C45H83N3O13
Reinheit:99% HPLC
Katalognummer:CM1075330
Molekulargewicht:874.17

Packungseinheit Verfügbarer Vorrat Preis($) Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1188328-37-1
Molekulare Formel:C45H83N3O13
Schmelzpunkt:-
SMILES-Code:CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(O)=O)C(=O)OC(C)(C)C
Dichte:
Katalognummer:CM1075330
Molekulargewicht:874.17
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Fatty Acid Modified Side Chains
Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.